AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Dermapharm Holding SE

Director's Dealing Jun 24, 2025

97_dirs_2025-06-24_ee626236-1d5e-47b7-8174-170c5f0ae32b.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 24 June 2025 16:46

Dermapharm Holding SE: Dr. Andreas Eberhorn, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

24.06.2025 / 16:45 CET/CEST

The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title: Dr.
First name: Andreas
Last name(s): Eberhorn

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Dermapharm Holding SE

b) LEI

5299009F0KNZINQQQK37

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE000A2GS5D8

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
33.50 EUR 49,982.00 EUR

d) Aggregated information

Price Aggregated volume
33.5000 EUR 49,982.0000 EUR

e) Date of the transaction

23/06/2025; UTC+2

f) Place of the transaction

Outside a trading venue


24.06.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de
End of News EQS News Service

99514  24.06.2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.